We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mixed Verdict on Boston Scientific Patents

By HospiMedica staff writers
Posted on 18 Dec 2000
Boston Scientific Corp. More...
(Natick, MA, USA) has announced that a jury in a patent infringement case involving the company's NIR stent, brought by Johnson & Johnson (J&J, New Brunswick, NJ, USA), has ruled in Boston Scientific's favor on three of the four patents at issue. The jury ruled in Boston Scientific's favor on five of the six claims at issue. The jury found that Boston Scientific infringed only one valid claim.

"We hope to persuade the judge to set aside the lone finding of infringement,” said Jim Tobin, president and CEO of Boston Scientific. "We will also present evidence in a separate hearing that these patents were improperly obtained by J&J and should therefore be unenforceable.”

The NIR stent with its multicellular design was developed and is manufactured by Medinol, Ltd. (Jerusalem, Israel). Boston Scientific has an exclusive worldwide license to market and distribute the NIR stent.



Related Links:
Boston Scientific

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Medical-Grade Display
HL2316SHTB
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.